ArticlePain and therapy2026

Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.

Jody L Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.